TriGemX Bio
TriGemX Bio uses the science of gut-brain biology to create medicines that transform human health.
$94M ·
Led by TCG Crossover · Source: businesswire.com
Funding history ↓Acquired by TTCGX Acquisition on · Seeking Alpha on MSN.
Signals
TriGemX Bio | 21 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Round | $94M | businesswire.com |
Timeline
- Acquired by
TTCGX Acquisition
Source: Seeking Alpha on MSN - Website created
Founders and team
AR
Alex Rives FounderCZ
Charles Zuker FounderRA
Richard Axel FounderTM
Thomas Maniatis FounderAK
Anita Kawatra EVP, Corporate AffairsBL
Brett Lauring Chief Medical OfficerFS
Fernando Salles Chief Business OffcierJG
Jay Galeota President & Chief Executive OfficerPF
Patrick Flanigan III Chief Financial OfficerSP
Shirly Pinto Chief Scientific Officer
Investors
BBill & Melinda Gates Foundation
BBill Gates
CCasdin Capital
- EEuclidean Capital
PPolaris
TTao Capital
TTCG Crossoverlead investor
TThe Column Grouplead investor
VViking Global Investors
Companies like TriGemX Bio
IIntrinsic Medicine (fka Lupa Bio)
MMirador Therapeutics$250M Series B+ · Jan 2026
VViewsML$4.9M Seed · Apr 2026
MManas AI$26M Seed · Sep 2025
BBraingoodSeed · Jul 2026
HHotSpot Therapeutics$100M Series B+ · Nov 2021
Other companies backed by TCG Crossover
SSoufflé Therapeutics$135M Series B+ · Oct 2026
VVaderis Therapeutics$152M Series B+ · Aug 2026
CCorxel$287M Series B+ · Jan 2026MMirador Therapeutics$250M Series B+ · Jan 2026
AArbor Biotechnologies$74M Series B+ · Mar 2025
PPathalys$105M Series B+ · Aug 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/trigemx-bio (get a free API key).